346 related articles for article (PubMed ID: 23183445)
41. A comparative study between conventional pan coater and quasi-continuous small batch coater on the stability of tablets containing acetylsalicylic acid.
Cahyadi C; Chan LW; Heng PW
Eur J Pharm Biopharm; 2015 Feb; 90():30-7. PubMed ID: 25448074
[TBL] [Abstract][Full Text] [Related]
42. Impact of excipients on coating efficiency in dry powder coating.
Smikalla M; Mescher A; Walzel P; Urbanetz NA
Int J Pharm; 2011 Feb; 405(1-2):122-31. PubMed ID: 21145382
[TBL] [Abstract][Full Text] [Related]
43. Preparation and evaluation of sustained-release matrix tablets based on metoprolol and an acrylic carrier using injection moulding.
Quinten T; Andrews GP; De Beer T; Saerens L; Bouquet W; Jones DS; Hornsby P; Remon JP; Vervaet C
AAPS PharmSciTech; 2012 Dec; 13(4):1197-211. PubMed ID: 22965662
[TBL] [Abstract][Full Text] [Related]
44. Dry powder coated osmotic drug delivery system.
Yang Q; Ma Y; Zhu J
Eur J Pharm Sci; 2018 Jan; 111():383-392. PubMed ID: 28986194
[TBL] [Abstract][Full Text] [Related]
45. Combination of a hot-melt subcoating and an enteric coating for moisture protection of hygroscopic Sennae fructus tablets.
Zier KI; Schultze W; Leopold CS
Pharm Dev Technol; 2019 Dec; 24(10):1210-1217. PubMed ID: 31354006
[TBL] [Abstract][Full Text] [Related]
46. Development of an enteric coating formulation and process for tablets primarily composed of a highly water-soluble, organic acid.
Crotts G; Sheth A; Twist J; Ghebre-Sellassie I
Eur J Pharm Biopharm; 2001 Jan; 51(1):71-6. PubMed ID: 11154906
[TBL] [Abstract][Full Text] [Related]
47. Cellulose Acetate Butyrate: Ammonio Methacrylate Copolymer Blends as a Novel Coating in Osmotic Tablets.
Ali R; Walther M; Bodmeier R
AAPS PharmSciTech; 2018 Jan; 19(1):148-154. PubMed ID: 28634790
[TBL] [Abstract][Full Text] [Related]
48. Dry powder coating of pharmaceuticals: a review.
Sauer D; Cerea M; DiNunzio J; McGinity J
Int J Pharm; 2013 Dec; 457(2):488-502. PubMed ID: 23428881
[TBL] [Abstract][Full Text] [Related]
49. Solubility parameters of hypromellose acetate succinate and plasticization in dry coating procedures.
Klar F; Urbanetz NA
Drug Dev Ind Pharm; 2016 Oct; 42(10):1621-35. PubMed ID: 26925982
[TBL] [Abstract][Full Text] [Related]
50. Design and study of ibuprofen disintegrating sustained-release tablets comprising coated pellets.
Abbaspour MR; Sadeghi F; Afrasiabi Garekani H
Eur J Pharm Biopharm; 2008 Mar; 68(3):747-59. PubMed ID: 17977701
[TBL] [Abstract][Full Text] [Related]
51. Development of a novel tablet-in-capsule formulation of mesalamine for inflammatory bowel disease.
Patel MM; Amin AF
Pharm Dev Technol; 2013; 18(2):390-400. PubMed ID: 22304735
[TBL] [Abstract][Full Text] [Related]
52. Polymer blends used for the aqueous coating of solid dosage forms: importance of the type of plasticizer.
Lecomte F; Siepmann J; Walther M; MacRae RJ; Bodmeier R
J Control Release; 2004 Sep; 99(1):1-13. PubMed ID: 15342176
[TBL] [Abstract][Full Text] [Related]
53. Compression of pellets coated with various aqueous polymer dispersions.
Dashevsky A; Kolter K; Bodmeier R
Int J Pharm; 2004 Jul; 279(1-2):19-26. PubMed ID: 15234790
[TBL] [Abstract][Full Text] [Related]
54. An investigation into moisture barrier film coating efficacy and its relevance to drug stability in solid dosage forms.
Mwesigwa E; Basit AW
Int J Pharm; 2016 Jan; 497(1-2):70-7. PubMed ID: 26551674
[TBL] [Abstract][Full Text] [Related]
55. Eudragit E as coating material for the pH-controlled drug release in the topical treatment of inflammatory bowel disease (IBD).
Leopold CS; Eikeler D
J Drug Target; 1998; 6(2):85-94. PubMed ID: 9886233
[TBL] [Abstract][Full Text] [Related]
56. Preparation and characterization of a powder containing an oily liquid drug with Eudragit EPO or L100 copolymer.
Fujii M; Kawakami A; Saito A; Tuchiya H; Koizumi N; Watanabe Y
Pharm Dev Technol; 2016 Dec; 21(8):1023-1028. PubMed ID: 26376360
[TBL] [Abstract][Full Text] [Related]
57. The influence of plasticizer on heat-humidity curing of cellulose acetate phthalate coated beads.
Williams RO; Liu J
Pharm Dev Technol; 2001 Nov; 6(4):607-19. PubMed ID: 11775961
[TBL] [Abstract][Full Text] [Related]
58. High efficiency dry coating of non-subcoated pellets for sustained drug release formulations using amino methacrylate copolymers.
Klar F; Urbanetz NA
Pharm Dev Technol; 2018 Dec; 23(10):1088-1096. PubMed ID: 29192521
[TBL] [Abstract][Full Text] [Related]
59. Combination of time-dependent and pH-dependent polymethacrylates as a single coating formulation for colonic delivery of indomethacin pellets.
Akhgari A; Sadeghi F; Garekani HA
Int J Pharm; 2006 Aug; 320(1-2):137-42. PubMed ID: 16782290
[TBL] [Abstract][Full Text] [Related]
60. Preparation and evaluation of sustained-release doxazosin mesylate pellets.
Ha JM; Kim JY; Oh TO; Rhee YS; Chi SC; Kuk H; Park CW; Park ES
Chem Pharm Bull (Tokyo); 2013; 61(4):371-8. PubMed ID: 23385960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
